ANUH PHARMA Financial Statement Analysis
|
||
|
The Revenues of ANUH PHARMA have increased by 22.66% YoY .
The Earnings Per Share (EPS) of ANUH PHARMA has increased by 65.93 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ANUH PHARMA Last 5 Annual Financial Results
[BOM: 506260]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹647 Cr | ₹527 Cr | ₹487 Cr | ₹432 Cr | ₹307 Cr |
| Expenses | ₹571 Cr | ₹476 Cr | ₹439 Cr | ₹387 Cr | ₹284 Cr |
| Operating Profit (Excl OI) | ₹76 Cr | ₹52 Cr | ₹47 Cr | ₹45 Cr | ₹23 Cr |
| Other Income | ₹12 Cr | ₹6.12 Cr | ₹5.20 Cr | ₹11 Cr | ₹4.21 Cr |
| Interest | ₹0.96 Cr | ₹0.75 Cr | ₹1.58 Cr | ₹2.03 Cr | ₹1.26 Cr |
| Depreciation | ₹8.58 Cr | ₹9.70 Cr | ₹12 Cr | ₹15 Cr | ₹7.03 Cr |
| Profit Before Tax | ₹78 Cr | ₹47 Cr | ₹39 Cr | ₹39 Cr | ₹19 Cr |
| Profit After Tax | ₹60 Cr | ₹36 Cr | ₹31 Cr | ₹28 Cr | ₹14 Cr |
| Earnings Per Share (Rs) | ₹11.98 | ₹7.22 | ₹6.10 | ₹5.67 | ₹5.71 |
| PAT Margin (%) | 9.24 | 6.83 | 6.22 | 6.46 | 4.50 |
| ROE(%) | 22.56 | 15.90 | 15.11 | 16.12 | 8.75 |
| ROCE(%) | 29.66 | 21.05 | 19.33 | 19.75 | 10.87 |
| Total Debt/Equity(x) | 0.01 | 0.00 | 0.01 | 0.07 | 0.27 |
Key Financials |
||
| Market Cap | : | ₹ 1,079.9 Cr |
| Revenue (TTM) | : | ₹ 639.9 Cr |
| Net Profit(TTM) | : | ₹ 59.0 Cr |
| EPS (TTM) | : | ₹ 11.8 |
| P/E (TTM) | : | 18.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ANUH PHARMA | -2.2% | 9.1% | 52.5% |
| SUN PHARMACEUTICAL INDUSTRIES | 1% | 0.7% | 47.3% |
| CIPLA | 0.3% | -1.8% | 19.6% |
| DR REDDYS LABORATORIES | 6% | 11.8% | 20.3% |
| ZYDUS LIFESCIENCES | -1.5% | -0.1% | 47% |
| DIVIS LABORATORIES | -1.1% | -5.8% | 61.7% |
| MANKIND PHARMA | 3.7% | 11.4% | 59.4% |
| TORRENT PHARMACEUTICALS | 0.6% | 4.1% | 59.5% |
| LUPIN | 3.3% | 2.9% | 75.9% |
ANUH PHARMA Revenues
[BOM: 506260]
| Y-o-Y | 22.66 % |
| 5 Yr CAGR | 20.49 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹647 Cr | 22.66 | |
| Mar2023 | ₹527 Cr | 8.39 | |
| Mar2022 | ₹487 Cr | 12.66 | |
| Mar2021 | ₹432 Cr | 40.72 | |
| Mar2020 | ₹307 Cr | - | |
ANUH PHARMA Operating Profit
[BOM: 506260]
| Y-o-Y | 46.24 % |
| 5 Yr CAGR | 34.38 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹76 Cr | 46.24 | |
| Mar2023 | ₹52 Cr | 9.14 | |
| Mar2022 | ₹47 Cr | 5.20 | |
| Mar2021 | ₹45 Cr | 94.19 | |
| Mar2020 | ₹23 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 19.25 % |
| 5 Yr CAGR | 11.52 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 11.71% | 19.25 | |
| Mar2023 | 9.82% | 0.72 | |
| Mar2022 | 9.75% | -6.70 | |
| Mar2021 | 10.45% | 38.04 | |
| Mar2020 | 7.57% | - | |
ANUH PHARMA Profit After Tax
[BOM: 506260]
| Y-o-Y | 66.00 % |
| 5 Yr CAGR | 43.14 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹60 Cr | 66.00 | |
| Mar2023 | ₹36 Cr | 18.39 | |
| Mar2022 | ₹31 Cr | 7.47 | |
| Mar2021 | ₹28 Cr | 98.78 | |
| Mar2020 | ₹14 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 35.29 % |
| 5 Yr CAGR | 19.71 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 9.24 % | 35.29 | |
| Mar2023 | 6.83 % | 9.81 | |
| Mar2022 | 6.22 % | -3.72 | |
| Mar2021 | 6.46 % | 43.56 | |
| Mar2020 | 4.5 % | - | |
ANUH PHARMA Earnings Per Share (EPS)
[BOM: 506260]
| Y-o-Y | 65.93 % |
| 5 Yr CAGR | 20.35 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹12 | 65.93 | |
| Mar2023 | ₹7.22 | 18.36 | |
| Mar2022 | ₹6.10 | 7.58 | |
| Mar2021 | ₹5.67 | -0.70 | |
| Mar2020 | ₹5.71 | - | |
ANUH PHARMA Return on Capital Employed (ROCE)
[BOM: 506260]
| Y-o-Y | 40.90 % |
| 5 Yr CAGR | 28.52 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 29.66% | 40.90 | |
| Mar2023 | 21.05% | 8.90 | |
| Mar2022 | 19.33% | -2.13 | |
| Mar2021 | 19.75% | 81.69 | |
| Mar2020 | 10.87% | - | |
ANUH PHARMA Share Price vs Sensex
| Current Share Price | : | ₹215.6 |
| Current MarketCap | : | ₹ 1,079.9 Cr |
| Updated EOD on | : | Dec 26,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -2.2% |
9.1% |
52.5% |
| SENSEX | -2.1% |
-2% |
11.3% |
ANUH PHARMA related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about ANUH PHARMA Financials
How the annual revenues of ANUH PHARMA have changed ?
The Revenues of ANUH PHARMA have increased by 22.66% YoY .
How the Earnings per Share (EPS) of ANUH PHARMA have changed?
The Earnings Per Share (EPS) of ANUH PHARMA has increased by 65.93 % YoY .
Check out Intrinsic Value of Peers of ANUH PHARMA
Compare Stock Analytics of Peers of ANUH PHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
